Although the journey to clinically establish the efficacy and safety of LCN2's anorexic effects is still ongoing, an intriguing perspective emerges: could the development of an anti‐LCN2 agent hold the potential to stimulate appetite, particularly in situations like cancer‐induced cachexia? Here, LCN2 is linked to cancer.